|Grant Affiliation:||Frank: Studies to Maximize Immunogenicity|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2012-08-31|
|Study Made Public:||2013-04-02|
HIV-1 envelope vaccine: neglected sugar interactions may determine vaccine success
CAVD 386 is a preclinical guinea pig study investigating in vivo survival of, and complement binding by, Env antigen, in protein/adjuvant regimens.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.